Nitisinone is an example of: (A) Enzyme activation therapy, (B) Enzyme replacement therapy, (C) Substrate addition therapy, (D) Substrate reduction therapy
Answer is D. Nitisinone is prescribed for infantile tyrosinemia because it decreases production of the substrate (fumarylacetoacetate) for the hydrolase, thus decreasing the velocity of the reaction preventing substrate accumulation.